HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

S Kanzler Selected Research

S Kanzler Research Topics

Disease

8Neoplasms (Cancer)
10/2020 - 05/2001
5Liver Diseases (Liver Disease)
07/2008 - 04/2000
4Colorectal Neoplasms (Colorectal Cancer)
10/2020 - 08/2006
3Disease Progression
10/2020 - 11/2001
3Adenocarcinoma
01/2018 - 01/2010
3Autoimmune Hepatitis
08/2002 - 04/2000
2Pancreatic Neoplasms (Pancreatic Cancer)
01/2021 - 01/2018
2Exanthema (Rash)
01/2021 - 01/2018
2Thrombosis (Thrombus)
08/2007 - 03/2007
2Liver Cirrhosis (Hepatic Cirrhosis)
08/2007 - 11/2001
2Hemorrhage
10/2006 - 11/2004
2Fibrosis (Cirrhosis)
11/2001 - 05/2001
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021
1Pain (Aches)
01/2018
1Neoplasm Metastasis (Metastasis)
12/2014
1Lymphatic Metastasis
12/2014
1Biliary Tract Neoplasms (Biliary Tract Cancer)
12/2014
1Stomach Neoplasms (Stomach Cancer)
06/2011
1Necrosis
02/2010
1Cholangiocarcinoma
11/2007
1Anaphylaxis (Anaphylactic Shock)
11/2007
1Acute Liver Failure (Fulminant Hepatic Failure)
11/2007
1Portal Hypertension
08/2007
1Carcinoma (Carcinomatosis)
04/2007
1Ulcer
10/2006
1Cardiovascular Diseases (Cardiovascular Disease)
11/2004
1Esophagitis
01/2004
1Ureteral Calculi
12/2003
1Chronic Hepatitis C
11/2001
1Infections
11/2001
1Hepatitis C
11/2001
1Hepatocellular Carcinoma (Hepatoma)
08/2001
1Carcinogenesis
08/2001
1Biliary Liver Cirrhosis (Primary Biliary Cirrhosis)
04/2001
1Chronic Hepatitis B
08/2000

Drug/Important Bio-Agent (IBA)

3GemcitabineFDA Link
01/2021 - 12/2014
3Irinotecan (Camptosar)FDA LinkGeneric
06/2011 - 01/2010
3AutoantibodiesIBA
01/2004 - 04/2000
2Diethylnitrosamine (N-Nitrosodiethylamine)IBA
01/2017 - 08/2001
2Biomarkers (Surrogate Marker)IBA
12/2014 - 06/2011
2Oxaliplatin (Eloxatin)FDA LinkGeneric
09/2013 - 02/2010
2Capecitabine (Xeloda)FDA Link
09/2013 - 01/2010
2Fluorouracil (Carac)FDA LinkGeneric
06/2011 - 01/2010
2Azathioprine (Imuran)FDA LinkGeneric
10/2006 - 05/2001
2AntigensIBA
08/2002 - 04/2000
2liver antigen LA-1IBA
08/2002 - 04/2000
2Transforming Growth Factor beta (TGF-beta)IBA
11/2001 - 08/2001
1AfatinibIBA
01/2021
1Epidermal Growth Factor (EGF)IBA
01/2021
1Panitumumab (Vectibix)FDA Link
10/2020
1folfirinoxIBA
01/2018
1Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2018
1Transcription Factor 3IBA
01/2017
1Sorafenib (BAY 43-9006)FDA Link
12/2014
1Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA
12/2014
1Imatinib Mesylate (Gleevec)FDA Link
09/2013
1Bevacizumab (Avastin)FDA Link
09/2013
1XELOXIBA
09/2013
1ErbB Receptors (EGF Receptor)IBA
06/2011
1Cetuximab (Erbitux)FDA Link
06/2011
1Leucovorin (Folinic Acid)FDA Link
06/2011
1Monoclonal AntibodiesIBA
02/2010
1LigandsIBA
02/2010
1mapatumumabIBA
02/2010
1Cisplatin (Platino)FDA LinkGeneric
01/2010
1Mitomycin (Mitomycin-C)FDA LinkGeneric
11/2007
1Ethiodized Oil (Ethiodol)FDA Link
11/2007
1BilirubinIBA
08/2007
1Somatostatin Receptors (Somatostatin Receptor)IBA
04/2007
1SteroidsIBA
10/2006
1Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
11/2004
1AnticoagulantsIBA
11/2004
1AcidsIBA
01/2004
1AntibodiesIBA
08/2002
1EnzymesIBA
08/2002
1C-Reactive ProteinIBA
08/2001
1Phenobarbital (Luminal)FDA Link
08/2001
1CarcinogensIBA
08/2001
1Protein Isoforms (Isoforms)IBA
08/2001
1Transforming Growth Factor-beta Type II ReceptorIBA
08/2001
1Lamivudine (Epivir)FDA Link
08/2000

Therapy/Procedure

6Therapeutics
01/2021 - 05/2001
1Drug Therapy (Chemotherapy)
02/2010
1Conscious Sedation
07/2008
1Palliative Care (Palliative Therapy)
11/2007
1Contraindications
08/2007
1Immunotherapy
08/2006
1Endoscopes
01/2004
1Duodenoscopes
12/2003
1Liver Transplantation
05/2001